Annual EBITDA
$750.00M$98.20M-11.58%
Summary
- Current Value
- As of today, WST annual EBITDA is $750.00M, down -11.58% on
- Historical Performance
- WST annual EBITDA is down -14.87% over the past 3 years, and up +87.22% over the past 5 years
- All-Time High Comparison
- WST annual EBITDA is currently -15.17% below its historical high of $884.10M set on
- 3-Year Low Comparison
- WST annual EBITDA is at its 3-year low
- Sector Comparison
- WST annual EBITDA is higher than 93.05% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $750.00M | -11.6% | -14.9% | +87.2% | +330.8% | |
| Quarterly EBITDA | $216.70M | +4.2% | -0.3% | +55.6% | +413.5% | |
| TTM EBITDA | $796.00M | +6.6% | -11.9% | +62.8% | +319.4% | |
| Price | $277.88 | -16.4% | +19.5% | -8.6% | +1262.8% | |
| PE Ratio | 41.16 | -17.2% | +36.8% | -38.1% | +89.8% | |
| Annual Revenue | $2.89B | -2.0% | +2.2% | +56.9% | +174.0% | |
| Annual EPS | $6.69 | -15.2% | -22.9% | +108.5% | +530.7% | |
| Annual EBIT | $594.60M | -16.4% | -21.6% | +100.1% | +460.9% | |
| Annual Net Income | $492.70M | -17.0% | -25.6% | +103.8% | +578.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $884.10M | N/A | -15.2% |
| 5Y | $884.10M | -15.2% | |
| All | $884.10M | -15.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $750.00M | at low | |
| 5Y | $528.10M | N/A | +42.0% |
| All | $23.45M | +3098.1% |
EBITDA History
FAQ
What is the current annual EBITDA of WST?
As of today, WST annual EBITDA is $750.00M
What is 1-year change in WST annual EBITDA?
WST annual EBITDA is down -11.58% year-over-year
What is 3-year change in WST annual EBITDA?
WST annual EBITDA is down -14.87% over the past 3 years
How far is WST annual EBITDA from its all-time high?
WST annual EBITDA is currently -15.17% below its historical high of $884.10M set on December 31, 2022
How does WST annual EBITDA rank versus sector peers?
WST annual EBITDA is higher than 93.05% of companies in Healthcare sector
When is WST next annual earnings release?
The next annual earnings release for WST is on
Quarterly EBITDA
$216.70M$17.10M+8.57%
Summary
- Current Value
- As of today, WST quarterly EBITDA is $216.70M, up +8.57% on
- Historical Performance
- WST quarterly EBITDA is up +4.18% year-over-year, and down -0.32% over the past 3 years
- All-Time High Comparison
- WST quarterly EBITDA is currently -14.69% below its historical high of $254.00M set on
- 3-Year Low Comparison
- WST quarterly EBITDA is +33.27% above its 3-year low of $162.60M reached on
- Sector Comparison
- WST quarterly EBITDA is higher than 92.33% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $216.70M | +8.6% | +4.2% | -0.3% | +55.6% | |
| Annual EBITDA | $750.00M | – | -11.6% | -14.9% | +87.2% | |
| TTM EBITDA | $796.00M | +1.1% | +6.6% | -11.9% | +62.8% | |
| Price | $277.88 | +4.5% | -16.4% | +19.5% | -8.6% | |
| PE Ratio | 41.16 | +4.5% | -17.2% | +36.8% | -38.1% | |
| Quarterly Revenue | $804.30M | +5.0% | +7.7% | +17.2% | +46.7% | |
| Quarterly EPS | $1.93 | +6.1% | +4.1% | +21.1% | +77.6% | |
| Quarterly EBIT | $173.70M | +9.8% | +3.5% | -7.4% | +62.8% | |
| Quarterly Net Income | $140.00M | +6.2% | +2.9% | +16.1% | +70.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $216.70M | at high | |
| 3Y | $226.80M | -4.5% | |
| 5Y | $254.00M | -14.7% | |
| All | $254.00M | -14.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $168.40M | +28.7% | |
| 3Y | $162.60M | +33.3% | |
| 5Y | $150.80M | N/A | +43.7% |
| All | -$192.90M | +212.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of WST?
As of today, WST quarterly EBITDA is $216.70M
What is WST quarterly EBITDA most recent change?
WST quarterly EBITDA was up +8.57% on September 30, 2025
What is 1-year change in WST quarterly EBITDA?
WST quarterly EBITDA is up +4.18% year-over-year
How far is WST quarterly EBITDA from its all-time high?
WST quarterly EBITDA is currently -14.69% below its historical high of $254.00M set on June 30, 2022
How does WST quarterly EBITDA rank versus sector peers?
WST quarterly EBITDA is higher than 92.33% of companies in Healthcare sector
When is WST next earnings release?
The next earnings release for WST is on
TTM EBITDA
$796.00M$8.70M+1.11%
Summary
- Current Value
- As of today, WST TTM EBITDA is $796.00M, up +1.11% on
- Historical Performance
- WST TTM EBITDA is up +6.59% year-over-year, and down -11.86% over the past 3 years
- All-Time High Comparison
- WST TTM EBITDA is currently -11.86% below its historical high of $903.10M set on
- 3-Year Low Comparison
- WST TTM EBITDA is +6.59% above its 3-year low of $746.80M reached on
- Sector Comparison
- WST TTM EBITDA is higher than 92.06% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $796.00M | +1.1% | +6.6% | -11.9% | +62.8% | |
| Annual EBITDA | $750.00M | – | -11.6% | -14.9% | +87.2% | |
| Quarterly EBITDA | $216.70M | +8.6% | +4.2% | -0.3% | +55.6% | |
| Price | $277.88 | +4.5% | -16.4% | +19.5% | -8.6% | |
| PE Ratio | 41.16 | +4.5% | -17.2% | +36.8% | -38.1% | |
| TTM Revenue | $3.02B | +1.9% | +4.9% | +3.8% | +47.8% | |
| TTM EPS | $6.75 | +1.1% | +0.1% | -18.7% | +63.8% | |
| TTM EBIT | $630.90M | +0.9% | +5.8% | -19.0% | +67.0% | |
| TTM Net Income | $491.70M | +0.8% | -1.6% | -22.0% | +57.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $796.00M | at high | |
| 3Y | $880.70M | N/A | -9.6% |
| 5Y | $903.10M | -11.9% | |
| All | $903.10M | -11.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $751.60M | N/A | +5.9% |
| 3Y | $746.80M | +6.6% | |
| 5Y | $535.00M | N/A | +48.8% |
| All | -$171.90M | +563.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of WST?
As of today, WST TTM EBITDA is $796.00M
What is WST TTM EBITDA most recent change?
WST TTM EBITDA was up +1.11% on September 30, 2025
What is 1-year change in WST TTM EBITDA?
WST TTM EBITDA is up +6.59% year-over-year
How far is WST TTM EBITDA from its all-time high?
WST TTM EBITDA is currently -11.86% below its historical high of $903.10M set on September 30, 2022
How does WST TTM EBITDA rank versus sector peers?
WST TTM EBITDA is higher than 92.06% of companies in Healthcare sector
When is WST next earnings release?
The next earnings release for WST is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- WST Official Website www.westpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/105770/000010577025000093/0000105770-25-000093-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/105770/000010577025000013/0000105770-25-000013-index.htm
- WST Profile on Yahoo Finance finance.yahoo.com/quote/WST
- WST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wst